Century Therapeutics (IPSC) Amortizatization of Intangibles (2024 - 2026)
Century Therapeutics' (IPSC) quarterly Amortizatization of Intangibles came in at $211000.0 in Q1 2026, down 75.29% year-on-year from $854000.0 in Q1 2025, and down 39.54% on a QoQ basis from $349000.0 in Q4 2025.
Century Therapeutics (IPSC) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 3 years of Amortizatization of Intangibles data on file, last reported at $211000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 75.29% year-over-year to $211000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 62.34% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 51.02% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $211000.0, down from $349000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for IPSC reached as high as $1.3 million in Q2 2024 and fell as low as $211000.0 in Q1 2026.
- Historically, Amortizatization of Intangibles has averaged $820000.0 across 3 years, with a median of $854000.0 in 2025.
- Across the five-year window, Amortizatization of Intangibles slipped 23.41% in 2025 and tumbled 75.29% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.0 million in 2024, then sank by 66.21% to $349000.0 in 2025, then slumped by 39.54% to $211000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $211000.0 in Q1 2026, $349000.0 in Q4 2025, and $507000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | 211,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211,000.00 |
| Mar 31, 2026 | 211,000.00 |
| Dec 31, 2025 | 349,000.00 |
| Dec 31, 2025 | 349,000.00 |
| Sep 30, 2025 | 507,000.00 |
| Sep 30, 2025 | 507,000.00 |
| Jun 30, 2025 | 647,000.00 |
| Jun 30, 2025 | 647,000.00 |
| Mar 31, 2025 | 854,000.00 |
| Mar 31, 2025 | 854,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.12 Mn |